Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
11
NCT04679194
Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 8, 2020
Completion: Mar 28, 2023